News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kelly Thomas Patrick
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,368 shares
@ $9.05, valued at
$12.4k
|
|
| 01/20/2022 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 20,500 shares
@ $0
Granted 82,000 options to buy
@ $8.27, valued at
$678.1k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2020 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $50.0121, valued at
$150k
Exercised 3,000 options to buy
@ $1.89, valued at
$5.7k
|
|
| 09/10/2020 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 800 shares
@ $44.6944, valued at
$35.8k
Sold 3,700 shares
@ $45.2295, valued at
$167.3k
Sold 1,500 shares
@ $46.5497, valued at
$69.8k
Sold 3,000 shares
@ $47.7087, valued at
$143.1k
Exercised 6,000 options to buy
@ $1.89, valued at
$11.3k
Exercised 3,000 options to buy
@ $1.89, valued at
$5.7k
|
|
| 05/13/2020 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 9,395 shares
@ $55.0842, valued at
$517.5k
Sold 2,605 shares
@ $55.5563, valued at
$144.7k
Exercised 12,000 options to buy
@ $1.89, valued at
$22.7k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 177 shares
@ $25, valued at
$4.4k
Exercised 177 options to buy
@ $1.89, valued at
$334.5 |
|
| 06/05/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,100 shares
@ $25.2033, valued at
$52.9k
Exercised 2,100 options to buy
@ $1.89, valued at
$4k
|
|
| 05/23/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,373 shares
@ $25.0683, valued at
$34.4k
Sold 100 shares
@ $25, valued at
$2.5k
Exercised 1,373 options to buy
@ $1.89, valued at
$2.6k
Exercised 100 options to buy
@ $1.89, valued at
$189 |
|
| 05/03/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 13,500 shares
@ $22.9277, valued at
$309.5k
Exercised 13,500 options to buy
@ $1.89, valued at
$25.5k
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $26.35, valued at
$2M
|
|
| 01/09/2019 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $25.18, valued at
$125.9k
Exercised 5,000 options to buy
@ $1.89, valued at
$9.5k
|
|
| 02/20/2018 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 90,000 options to buy
@ $29.71, valued at
$2.7M
|
|
|
|